IDEAYA Biosciences (IDYA) Misses Q4 EPS by 5c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($0.52), $0.05 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $8.84 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Atlassian results seen as 'game changer' for AI kills software worries
• Mammoth Energy Services (TUSK) Reports Q2 Loss of $0.01